CSIR-NCL Develops an Anti-TB Co-crystal 4-FDC Drug with Improved Stability

FDA Approves Datopotamab Deruxtecan for Second Indication 45 Percent Response Rate in EGFR Mutant Lung Cancer

UK Parliament Approves Assisted Dying Bill 7500 Could Seek Euthanasia Annually

4 Pharma Firms Lose Licenses in Jammu and Kashmir Amid Illegal Drug Sales Crackdown

Over 100 Foreign Pharma Executives Join Chinese Firms in 5 Years Industry Faces Key Challenges

Merck’s New CMV Drug Approved in China Targets Nearly 40000 HSCT Patients

Trump Warns of 200 Percent Tariffs on Pharma Companies by August 1 India Trade Deal Among Top Priorities

Emcure Seals Exclusive Deal for Sanofi’s Oral Diabetes Brands Millions of Indian Patients to Benefit

AstraZeneca Rare Disease Drug Misses Phase 3 Target Hope Shifts to Subgroup Data

Over 22,000 New Cases in India AstraZeneca Gets CDSCO Green Light for Muscle-Invasive Bladder Cancer Drug

60 Percent Workforce Held by Top 10 Firms! China’s TCM Industry Faces Fierce Reshuffle as Private Leaders Expand Fast